시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 표층점상각막염 치료 시장 보고서(2025년)
Superficial Punctate Keratitis Treatment Global Market Report 2025
상품코드 : 1720900
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,151,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,891,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,632,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

표층점상각막염 치료 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 안구건조증 유병률 증가, 콘택트렌즈 사용 증가, 눈 건강에 대한 인식 증대, 신흥 경제국의 의료 인프라 확장, 그리고 맞춤형 치료에 대한 관심 증가에 의한 것으로 예측됩니다. 주요 동향으로서는 각막 치유를 개선하는 약제 제제의 발전, 표적 생물 제제의 개발, 안윤활제나 인공눈물의 혁신, 드러그 딜리버리를 위한 나노 테크놀로지의 통합, 저침습 수술 기술의 진보, 줄기세포 등의 재생 치료법의 이용 등이 있습니다.

눈 질환의 유병률 증가는 표층점상각막염 치료 시장의 성장을 가속할 것으로 예측됩니다. 인구 고령화, 장기간의 화면 노출, 당뇨병, 오염 및 자외선과 같은 환경 요인으로 인한 것입니다. Health Improvement and Disparities 사무소는 잉글랜드가 2023년 회계연도에 890만명 이상의 시력 외래 진찰을 기록했으며, 인구 10만명당 진찰률은 1만5,362명으로 전년도 1만4,613명에서 증가했다고 보고했습니다.

표층점상각막염 치료 시장의 주요 기업은 염증에 대처하고 효과적이고 비침습적인 치료 옵션을 제공하기 위해 진화된 점안약 등의 혁신적인 제품에 주력하고 있습니다. Pharmaceuticals는 염증성 안구건조증(DED)으로 고통받는 사람들을 위해 인도 및 기타 세계 시장에서 CYCLOTEARS 점안제를 출시했습니다. 독창적인 기술 인자가 유화형 약물 전달 시스템(SEDDS) 기술을 도입한 세계 최초의 안구건조증 치료제입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Superficial punctate keratitis (SPK) treatment involves managing corneal irritation caused by factors such as dry eyes, infections, or environmental stress. Treatment options include lubricating eye drops, anti-inflammatory medications, and addressing underlying conditions to promote healing. The primary goals of treatment are to relieve discomfort, reduce inflammation, and restore corneal health.

The key product categories in the superficial punctate keratitis treatment market include pharmacological treatments, surgical procedures, minimally invasive interventions, digital health solutions (such as telemedicine and mobile applications), and other treatment options. Pharmacological treatments consist of medications such as antibiotics, antifungals, and anti-inflammatory eye drops that help combat infections and reduce inflammation. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies and are utilized by various end-users, including hospitals, ophthalmology clinics, home care settings, and ambulatory surgical centers.

The superficial punctate keratitis treatment market research report is one of a series of new reports from The Business Research Company that provides superficial punctate keratitis treatment market statistics, including the superficial punctate keratitis treatment industry's global market size, regional shares, competitors with a superficial punctate keratitis treatment market share, detailed superficial punctate keratitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the superficial punctate keratitis treatment industry. This superficial punctate keratitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The superficial punctate keratitis treatment market size has grown strongly in recent years. It will grow from $4.91 billion in 2024 to $5.25 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be credited to the rising prevalence of ocular surface disorders, increased awareness of eye health, growing demand for topical treatments, an expanding geriatric population, improvements in healthcare infrastructure, and heightened R&D activities in ophthalmology.

The superficial punctate keratitis treatment market size is expected to see strong growth in the next few years. It will grow to $6.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth during the forecast period can be credited to the increasing prevalence of dry eye syndrome, rising use of contact lenses, greater awareness of eye health, expanding healthcare infrastructure in emerging economies, and a growing focus on personalized treatments. Key trends include advancements in drug formulations for improved corneal healing, the development of targeted biologics, innovations in ocular lubricants and artificial tears, integration of nanotechnology for drug delivery, progress in minimally invasive surgical techniques, the use of regenerative therapies such as stem cells, and the adoption of digital diagnostics for personalized treatment plans.

The increasing prevalence of eye diseases is expected to drive the growth of the superficial punctate keratitis treatment market. Eye diseases encompass a range of conditions affecting vision and eye health, including infections, degenerative disorders, and structural abnormalities. The rising incidence of these conditions is attributed to aging populations, prolonged screen exposure, diabetes, and environmental factors such as pollution and UV radiation. Treatments for superficial punctate keratitis, including lubricating eye drops, antibiotics, and anti-inflammatory medications, help alleviate pain, reduce inflammation, and promote healing for corneal surface damage. For example, in May 2024, the Office for Health Improvement and Disparities, a UK-based government agency, reported that England recorded over 8.9 million vision outpatient attendances in the financial year ending 2023, with a rate of 15,362 per 100,000 population, up from 14,613 in the previous year. As a result, the increasing prevalence of eye diseases is fueling the demand for superficial punctate keratitis treatments.

Leading companies in the superficial punctate keratitis treatment market are focusing on innovative products, such as advanced eye drops, to address inflammation and provide effective, non-invasive treatment options. Eye drops, formulated as liquid solutions, are widely used to manage irritation, dryness, inflammation, and infections. For instance, in May 2023, Entod Pharmaceuticals, an India-based pharmaceutical company, introduced CYCLOTEARS eye drops in India and other global markets for individuals suffering from inflammatory dry eye disease (DED). This product is the first dry eye therapy worldwide to incorporate the company's self-emulsifying drug delivery system (SEDDS) technology, a breakthrough in treating eye inflammation. This cutting-edge formulation enhances drug absorption and efficacy, providing improved relief for patients.

In July 2024, Bausch + Lomb Corporation, a Canada-based eye health company, acquired Trukera Medical for an undisclosed amount. This acquisition is intended to expand Bausch + Lomb's surgical presence in the U.S. and strengthen its capabilities in dry eye management by integrating Trukera's scoutPro device, a valuable tool for pre-surgical assessment and optimization. Trukera Medical is a US-based company specializing in diagnostic tools, including the scoutPro, designed for assessing corneal health and diagnosing dry eye disease.

Major players in the superficial punctate keratitis treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc (GSK), Alcon Inc., Bausch + Lomb Corporation, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals plc, Santen Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Dompe Farmaceutici S.p.A., OASIS Medical Inc., Bruschettini S.r.l., Allergan plc, CONTACARE Ophthalmics Pvt. Ltd., and Prevego Healthcare Ltd.

North America was the largest region in the superficial punctate keratitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in superficial punctate keratitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the superficial punctate keratitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The superficial punctate keratitis treatment market consists of revenues earned by entities through services such as diagnosis and consultation, prescription services, specialized therapeutic procedures, post-treatment monitoring and follow-up, patient education, and preventive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The superficial punctate keratitis treatment market also includes sales of lubricating eye drops and artificial tears, topical medications, contact lenses, diagnostic tools, UV protection glasses, and shields. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Superficial Punctate Keratitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on superficial punctate keratitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for superficial punctate keratitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The superficial punctate keratitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Superficial Punctate Keratitis Treatment Market Characteristics

3. Superficial Punctate Keratitis Treatment Market Trends And Strategies

4. Superficial Punctate Keratitis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Superficial Punctate Keratitis Treatment Growth Analysis And Strategic Analysis Framework

6. Superficial Punctate Keratitis Treatment Market Segmentation

7. Superficial Punctate Keratitis Treatment Market Regional And Country Analysis

8. Asia-Pacific Superficial Punctate Keratitis Treatment Market

9. China Superficial Punctate Keratitis Treatment Market

10. India Superficial Punctate Keratitis Treatment Market

11. Japan Superficial Punctate Keratitis Treatment Market

12. Australia Superficial Punctate Keratitis Treatment Market

13. Indonesia Superficial Punctate Keratitis Treatment Market

14. South Korea Superficial Punctate Keratitis Treatment Market

15. Western Europe Superficial Punctate Keratitis Treatment Market

16. UK Superficial Punctate Keratitis Treatment Market

17. Germany Superficial Punctate Keratitis Treatment Market

18. France Superficial Punctate Keratitis Treatment Market

19. Italy Superficial Punctate Keratitis Treatment Market

20. Spain Superficial Punctate Keratitis Treatment Market

21. Eastern Europe Superficial Punctate Keratitis Treatment Market

22. Russia Superficial Punctate Keratitis Treatment Market

23. North America Superficial Punctate Keratitis Treatment Market

24. USA Superficial Punctate Keratitis Treatment Market

25. Canada Superficial Punctate Keratitis Treatment Market

26. South America Superficial Punctate Keratitis Treatment Market

27. Brazil Superficial Punctate Keratitis Treatment Market

28. Middle East Superficial Punctate Keratitis Treatment Market

29. Africa Superficial Punctate Keratitis Treatment Market

30. Superficial Punctate Keratitis Treatment Market Competitive Landscape And Company Profiles

31. Superficial Punctate Keratitis Treatment Market Other Major And Innovative Companies

32. Global Superficial Punctate Keratitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Superficial Punctate Keratitis Treatment Market

34. Recent Developments In The Superficial Punctate Keratitis Treatment Market

35. Superficial Punctate Keratitis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기